Studies have shown that GABAergic signals promote cell migration in gliomas by activating chloride channels, and targeted inhibition of GABRP may reverse this effect and weaken its ability to recruit regulatory T cells (Tregs) and M2 macrophages, thereby relieving immunosuppression. This evidence concerns the gene GABRP and central nervous system cancer.